Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M53,679Revenue $M19,118Net Margin (%)14.1Z-Score4.5
Enterprise Value $M53,496EPS $3.8Operating Margin %17.1F-Score6
P/E(ttm))20.7Cash Flow Per Share $3.8Pre-tax Margin (%)18.7Higher ROA y-yN
Price/Book2.610-y EBITDA Growth Rate %13.5Quick Ratio1.7Cash flow > EarningsY
Price/Sales2.85-y EBITDA Growth Rate %21.7Current Ratio2.2Lower Leverage y-yY
Price/Cash Flow14.1y-y EBITDA Growth Rate %5.0ROA % (ttm)7.8Higher Current Ratio y-yY
Dividend Yield %0.3Insider Buy (3m)0ROE % (ttm)12.0Less Shares Outstanding y-yN
Payout Ratio %7.0Shares Outstanding M700ROI % (ttm)9.9Gross Margin Increase y-yY

Gurus Latest Trades with DHR

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DHRChuck Akre 2014-06-30 Add2.72%$72.56 - $80.68
($76.38)
$ 76.610%Add 400%1,500,000
DHRJohn Burbank 2014-06-30 Add0.48%$72.56 - $80.68
($76.38)
$ 76.610%Add 114.69%674,148
DHRMario Gabelli 2014-06-30 Sold Out $72.56 - $80.68
($76.38)
$ 76.610%Sold Out0
DHRJoel Greenblatt 2014-06-30 Reduce-0.28%$72.56 - $80.68
($76.38)
$ 76.610%Reduce -80.2%60,559
DHRRay Dalio 2014-06-30 Reduce-0.02%$72.56 - $80.68
($76.38)
$ 76.610%Reduce -67.01%20,139
DHRJohn Burbank 2014-03-31 Add0.42%$72.49 - $78.53
($75.78)
$ 76.611%Add 185.47%314,012
DHRJoel Greenblatt 2014-03-31 Add0.33%$72.49 - $78.53
($75.78)
$ 76.611%Add 1305.55%305,861
DHRRay Dalio 2014-03-31 Buy 0.04%$72.49 - $78.53
($75.78)
$ 76.611%New holding, 61039 sh.61,039
DHRMario Gabelli 2014-03-31 Reduce$72.49 - $78.53
($75.78)
$ 76.611%Reduce -21.56%2,667
DHRChuck Akre 2013-12-31 Buy 0.8%$67.14 - $77.05
($73.15)
$ 76.615%New holding, 280000 sh.280,000
DHRJohn Burbank 2013-12-31 Add0.08%$67.14 - $77.05
($73.15)
$ 76.615%Add 37.5%110,000
DHRJohn Burbank 2013-09-30 Reduce-0.05%$63.63 - $70.49
($67.5)
$ 76.6114%Reduce -22.33%80,000
DHRJoel Greenblatt 2013-09-30 Reduce-0.02%$63.63 - $70.49
($67.5)
$ 76.6114%Reduce -21.56%20,506
DHRJohn Burbank 2013-06-30 Buy 0.21%$58.05 - $64.36
($61.61)
$ 76.6124%New holding, 103000 sh.103,000
DHRJoel Greenblatt 2013-06-30 Add0.01%$58.05 - $64.36
($61.61)
$ 76.6124%Add 26.25%26,143
DHRRay Dalio 2013-06-30 Sold Out -0.02%$58.05 - $64.36
($61.61)
$ 76.6124%Sold Out0
DHRRay Dalio 2013-03-31 Add0.01%$55.9 - $62.65
($60.69)
$ 76.6126%Add 105.67%37,739
DHRMario Gabelli 2013-03-31 Buy $55.9 - $62.65
($60.69)
$ 76.6126%New holding, 3400 sh.3,400
DHRJoel Greenblatt 2013-03-31 Reduce-0.03%$55.9 - $62.65
($60.69)
$ 76.6126%Reduce -32.27%20,708
DHRRay Dalio 2012-12-31 Buy 0.01%$51.41 - $56.83
($53.92)
$ 76.6142%New holding, 18349 sh.18,349
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DHR is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
DHR Chuck Akre 2014-06-301,500,0000.213.4+400%
DHR John Burbank 2014-06-30674,1480.10.9+114.69%
DHR Ruane Cunniff 2014-06-301,474,6960.210.62+0.04%
DHR Ray Dalio 2014-06-3020,13900.01-67.01%
DHR Joel Greenblatt 2014-06-3060,5590.010.06-80.2%
DHR Mario Gabelli 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


DHR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
King WilliamSenior Vice President 2014-08-01Sell3,545$73.743.89view
CULP H LAWRENCE JRPresident and CEO 2014-07-18Sell111,540$74.143.33view
SCHWIETERS JOHN TDirector 2014-05-28Sell8,000$78.73-2.69view
Graham Jonathan PSenior VP & GC 2014-05-12Sell9,973$752.15view
Joyce Thomas Patrick JREVP and CEO-Designate 2014-05-02Sell23,191$73.424.34view
COMAS DANIEL LEVP & CFO 2014-05-02Sell39,942$73.364.43view
Raskas DanielSVP-Corporate Development 2014-05-01Sell11,158$73.484.26view
LUTZ ROBERT SSVP-Chief Accounting Officer 2014-02-25Sell6,250$76.85-0.31view
COMAS DANIEL LEVP & CFO 2013-10-24Sell50,000$71.656.92view
Raskas DanielSVP-Corporate Development 2013-10-18Sell20,000$71.996.42view

Press Releases about DHR :

    Quarterly/Annual Reports about DHR:

    News about DHR:

    Articles On GuruFocus.com
    General Electric: A Leader in all Markets Jul 31 2014 
    A French Company Being Taken Over by a U.S. Rival Apr 25 2014 
    Pall Focus on Cost Reduction and R&D Progress in the Biotech Industry Mar 28 2014 
    3M Co: What Was Once Profitable… Still Is! Feb 25 2014 
    FLIR - Moving Forward Jan 09 2014 
    Why Should You Stay Away From Sevcon? Mario Gabelli Reduces Nov 28 2013 
    Weekly 52-Week High Stocks Sep 16 2013 
    Second Quarter Update - Three Diversified Industrials Aug 13 2013 
    Strong 3M Growth is Tempered by Weakening Margins Aug 03 2013 
    Weekly CFO Sells Highlight: TXN, AAPL, MAN, DHR, STJ, BAX Jul 29 2013 


    More From Other Websites
    Danaher (DHR) Highlighted As Storm The Castle Stock Aug 15 2014
    Will This Price Target Cut Hurt Danaher (DHR) Stock Today? Jul 29 2014
    DANAHER CORP /DE/ Financials Jul 23 2014
    Danaher (DHR) Falls: Stock Goes Down 5.6% Jul 18 2014
    Danaher earnings disappoint Jul 17 2014
    Danaher Q2 Earnings, Guidance Disappoint Wall Street Jul 17 2014
    Why Danaher (DHR) Stock Is Down Today Jul 17 2014
    Danaher Misses Q2 Earnings Estimates, Up Y/Y, Outlook Cut Jul 17 2014
    Danaher (DHR) Is Today's Roof Leaker Stock Jul 17 2014
    Q2 2014 Danaher Earnings Release - Before Market Open Jul 17 2014
    DANAHER CORP /DE/ Files SEC form 10-Q, Quarterly Report Jul 17 2014
    DANAHER CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 17 2014
    Danaher Reports Record Second Quarter 2014 Results Jul 17 2014
    Beckman Coulter to Acquire Siemens Healthcare Diagnostics' Clinical Microbiology Business Jul 16 2014
    Can Danaher (DHR) Keep the Earnings Streak Alive? Jul 14 2014
    Will earnings tell the story markets need to hear? Jul 13 2014
    Danaher Schedules Second Quarter 2014 Earnings Conference Call Jun 26 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK